AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2003_CD
75_CD
8_CD
Segment_NOMZ
information_NOMZ
The_DT
Groups_NN
activities_NOMZ
are_VPRT [BEMA]
predominantly_RB
in_PIN
one_CD
class_NN
of_PIN
business_NOMZ
,_,
pharmaceuticals_NN
._.
There_EX
are_VPRT
no_SYNE
other_JJ
significant_JJ
classes_NN
of_PIN
business_NOMZ
,_,
either_CC
singularly_RB
or_CC
in_PIN
aggregate_NN
._.
Geographic_JJ
areas_NN
The_DT
tables_NN
below_PLACE
show_NN
information_NOMZ
by_PIN
geographic_JJ
area_NN
and_CC
,_,
for_PIN
turnover_NN
and_CC
tangible_JJ
fixed_VBN
assets_NN
,_,
material_NN
countries_NN
._.
The_DT
figures_NN
show_VPRT [PRIV]
the_DT
turnover_NN
,_,
operating_VBG
profit_NN
and_PHC
profit_NN
on_PIN
ordinary_JJ
activities_NOMZ
before_IN
interest_NN
and_PHC
taxation_NOMZ
made_VBN [WZPAST]
by_PIN
companies_NN
located_VBN [WZPAST]
in_PIN
that_DEMO
area_NN
country_NN
,_,
together_RB
with_PIN
net_JJ
operating_GER
assets_NN
and_CC
tangible_JJ
fixed_VBN
assets_NN
owned_VBN [WZPAST]
by_PIN
the_DT
same_JJ
companies_NN
:_:
export_NN
sales_NN
and_CC
the_DT
related_JJ
profit_NN
are_VPRT [PASS]
included_VBN
in_PIN
the_DT
areas_NN
country_NN
from_PIN
which_WDT [PIRE]
those_DEMO
sales_NN
were_VBD [PASS]
made_VBN
._.
In_PIN
the_DT
US_FPP1
,_,
sales_NN
to_PIN
five_CD
wholesalers_NN
accounted_VBD
for_PIN
87_CD
%_NN
of_PIN
our_FPP1
US_FPP1
sales_NN
._.
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
76_CD
Form_NN
20-F_JJ
Information_NOMZ
2003_CD
Notes_NN
to_PIN
the_DT
Financial_NN
Statements_NOMZ
continued_VBD
8_CD
Segment_NOMZ
information_NOMZ
continued_VBD
Profit_NN
on_PIN
ordinary_JJ
Operating_GER
profit_NN
activities_NOMZ
before_IN
after_IN
exceptional_JJ
items_NN
interest_NN
and_PHC
taxation_NOMZ
2003 2002 2001 2003_CD
2002_CD
2001_CD
Profit_NN
from_PIN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
UK_NN
810 672 520 812_CD
673_CD
523_CD
Continental_NN
Europe_NN
2,241_CD
1,689_CD
1,400_CD
2,241_CD
1,689_CD
1,405_CD
The_DT
Americas_NN
816_CD
1,473_CD
1,904_CD
816_CD
1,473_CD
1,914_CD
Asia_NN
,_,
Africa_NN
&_CC
Australasia_NN
244 172 130 244_CD
172_CD
130_CD
Continuing_VBG
operations_NOMZ
4,111_CD
4,006_CD
3,954_CD
4,113_CD
4,007_CD
3,972_CD
Net_NN
operating_VBG [WZPRES]
assets_NN
2003 2002 2001_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
UK_NN
4,146_CD
3,101_CD
2,558_CD
Continental_NN
Europe_NN
5,771_CD
4,805_CD
4,940_CD
The_DT
Americas_NN
1,931_CD
1,004_CD
614_CD
Asia_NN
,_,
Africa_NN
&_CC
Australasia_NN
1,033_CD
958_CD
696_CD
Continuing_VBG
operations_NOMZ
12,881_CD
9,868_CD
8,808_CD
Net_NN
operating_VBG [WZPRES]
assets_NN
exclude_VPRT
short_JJ
term_NN
investments_NOMZ
,_,
cash_NN
,_,
short_JJ
term_NN
borrowings_GER
,_,
loans_NN
and_CC
non-operating_JJ
debtors_NN
and_PHC
creditors_NN
._.
Tangible_JJ
fixed_JJ
assets_NN
2003 2002 2001_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
UK_NN
2,502_CD
2,319_CD
1,881_CD
Sweden_NN
2,122_CD
1,626_CD
1,251_CD
US_FPP1
1,095_CD
1,031_CD
895_CD
Others_NN
1,817_CD
1,621_CD
1,382_CD
Continuing_VBG
operations_NOMZ
7,536_CD
6,597_CD
5,409_CD
Geographic_JJ
markets_NN
The_DT
table_NN
below_PLACE
shows_NN
turnover_NN
in_PIN
each_QUAN
geographic_JJ
market_NN
in_PIN
which_WDT [PIRE]
customers_NN
are_VPRT [PASS]
located_VBN
._.
